Protective effect of resveratrol against pembrolizumab‐induced hepatotoxicity and neurotoxicity in male rats
Journal of Biochemical and Molecular Toxicology · 2023-03 · 37 (3)
DOI: 10.1002/jbt.23263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 23.11.2022. Verfasst von Neşe B Türkmen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Inonu University, Malatya, Turkey. Hauptthemen laut MEDLINE: Oxidative Stress, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
The present study investigates the effects of resveratrol (RSV) on brain and liver tissues in rats with pembrolizumab (PEMB)‐induced toxicity. Obtained for the study were 28 male Sprague‐Dawley rats (3–4 months old) which were divided into four groups: Group 1: Control. Group 2: Administered PEMB at 5 mg/kg/day i.p. for a week. Group 3: Administered RSV orally at the dose of 20 mg/kg/day for 30 days by gavage. Group 4: Administered PEMB and RSV at 20 and 5 mg/kg/day RSV, respectively, for 30 days. The results of this study revealed that PEMB leads to a significant increase in thiobarbituric acid reactive substance (TBARS) levels and a significant decrease in glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD) activities, and glutathione (GSH) levels in the liver and brain tissues. The decreased SOD, CAT, GPx activities, and GSH levels increased significantly following RSV treatment in Group 4. The PEMB treatment showed histopathological alterations associated with strong positive cysteinyl aspartic acid‐protease‐3 (caspase‐3) immunoreactivity, while RSV treatment reduced both the expression of caspase‐3 protein and the histopathological changes. RSV administration prevents the biochemical, immunological, and histological alterations induced by PEMB. It can be suggested that the lower caspase‐3 immunoreactivity in the PEMB + RSV group than in the PEMB group led to an inhibition of RSV on apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Inonu University, Malatya, Turkey.
- Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey.
- Department of Pharmacy Services, Kovancilar Vocational School, Firat University, Elazig, Turkey.
ORCID-Profile: Neşe B Türkmen, Aslı Ç Taşlıdere, Dilan A Özek
Zitieren
APA
Türkmen, N. B., Yüce, H., Şahin, Y., Taşlıdere, A. Ç., Özek, D. A., Ünüvar, S., & Çiftçi, O. (2023). Protective effect of resveratrol against pembrolizumab‐induced hepatotoxicity and neurotoxicity in male rats. Journal of Biochemical and Molecular Toxicology, 37(3). https://doi.org/10.1002/jbt.23263
Vancouver
Türkmen NB, Yüce H, Şahin Y, Taşlıdere AÇ, Özek DA, Ünüvar S, et al. Protective effect of resveratrol against pembrolizumab‐induced hepatotoxicity and neurotoxicity in male rats. Journal of Biochemical and Molecular Toxicology. 2023;37(3). doi:10.1002/jbt.23263
BibTeX
@article{Trkmen2023,
author = {Türkmen, Neşe B and Yüce, Hande and Şahin, Yasemin and Taşlıdere, Aslı Ç and Özek, Dilan A and Ünüvar, Songül and Çiftçi, Osman},
title = {Protective effect of resveratrol against pembrolizumab‐induced hepatotoxicity and neurotoxicity in male rats},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
volume = {37},
number = {3},
doi = {10.1002/jbt.23263}
}
EUVIMED